Acute chest syndrome, a serious complication of sickle cell disease that can accompany a vaso-occlusive crisis, is more likely…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
More than a quarter of patients with sickle cell disease (SCD) are readmitted to the hospital within 30 days…
A new computer model is able to simulate how red blood cells become misshapen in patients with sickle cell disease. The…
Holistic Treatment Approach May Help Heal Long-Lasting SCD-Related Skin Ulcers, Case Report Shows
A newly developed treatment approach, known by the acronym SICKLE, was shown to be a safe strategy to manage and…
Students with sickle cell disease (SCD) feel that educators and administrators at their schools lack knowledge about SCD management —…
A simple blood test and other measures could help halt the rise of sickle cell anemia in Africa and prevent…
Researchers have pinpointed a specific genetic profile that could help identify sickle cell disease (SCD) patients who are at risk…
Researchers found that a new conditioning regimen for adult sickle cell disease (SCD) patients undergoing allogeneic peripheral blood stem cell…
Two Types of CRISPR Gene Editing Could Be Useful in Treating Sickle Cell Anemia, Editas Reports
Two kinds of CRISPR gene editing therapies show promise as treatments for a number of blood diseases, including sickle cell anemia, …
Researchers found that treatment with hydroxyurea at currently approved doses for sickle cell anemia leads to a significant drop…